Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation.

BACKGROUND Many tyrosinase inhibitors find application in cosmetics and pharmaceutical products for the prevention of the overproduction of melanin in the epidermis. A series of 5-(substituted benzylidene)hydantoin derivatives 2a-2k were prepared, and their inhibitory activities toward tyrosinase and melanin formation were evaluated. METHODS The structures of the compounds were established using (1)H and (13)C NMR spectroscopy and mass spectral analyses. All the synthesized compounds were evaluated for their mushroom tyrosinase inhibition activity. RESULTS The best results were obtained for compound 2e which possessed hydroxyl group at R(2) and methoxy group at R(3), respectively. We predicted the tertiary structure of tyrosinase, simulated its docking with compound 2e and confirmed that this compound interacts strongly with mushroom tyrosinase residues as a competitive tyrosinase inhibitor. In addition, we found that 2e inhibited melanin production and tyrosinase activity in B16 cells. CONCLUSIONS Compound 2e could be considered as a promising candidate for preclinical drug development in skin hyperpigmentation applications. GENERAL SIGNIFICANCE This study will enhance understanding of the mechanism of tyrosinase inhibition and will contribute to the development of effective drugs for use hyperpigmentation.

[1]  H. Chung,et al.  4,4'-Dihydroxybiphenyl as a new potent tyrosinase inhibitor. , 2005, Biological & pharmaceutical bulletin.

[2]  J. Na,et al.  Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. , 2005, Biological & pharmaceutical bulletin.

[3]  K. Rangappa,et al.  Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study , 2009, Investigational New Drugs.

[4]  Youngsoo Kim,et al.  Oxyresveratrol and Hydroxystilbene Compounds , 2002, The Journal of Biological Chemistry.

[5]  J. Menéndez,et al.  Synthesis, Anticonvulsant and Antihypertensive Activity of Diastereomeric 9,10-Dimethoxy-1,3,4,6,7,11b-hexahydrospiro(benzo(a) quinolizin-2,4′-imidazolidine)-2′,5′-diones. , 1992 .

[6]  H. M. Kim,et al.  Hydantoin derivative formation from oxidation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) and incorporation of 14C-labeled 8-oxodG into the DNA of human breast cancer cells. , 2005, Bioorganic & medicinal chemistry letters.

[7]  A. Ahlhelm,et al.  [Racemates and enantiomers of basic, substituted 5-phenylhydantoins, synthesis and anti-arrhythmic action]. , 1997, Die Pharmazie.

[8]  S. H. Kang,et al.  Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. , 1998, Biochemical and biophysical research communications.

[9]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[10]  R. Glen,et al.  Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor. , 1999, Journal of medicinal chemistry.

[11]  Hwan-Suck Chung,et al.  Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries , 2007, Phytotherapy research : PTR.

[12]  I. Kubo,et al.  Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. , 2000, Bioorganic & medicinal chemistry.

[13]  H. Chung,et al.  Inhibition of tyrosinase by protocatechuic aldehyde. , 2004, The American journal of Chinese medicine.

[14]  V. Kahn,et al.  Effect of methimazole on the activity of mushroom tyrosinase. , 1986, The Biochemical journal.

[15]  B. Tóth,et al.  Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides. , 2001, Journal of medicinal chemistry.

[16]  E. Camera,et al.  Chemical and instrumental approaches to treat hyperpigmentation. , 2003, Pigment cell research.

[17]  G. Martin,et al.  A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists. , 1997, Journal of medicinal chemistry.

[18]  A. Khodair Synthesis of arylidenehydrazono- and glycopyranosylhydrazino-sulfonylbenzylidene-2,4-imidazolidinediones as potential antiviral and antitumoral agents. , 1998, Carbohydrate research.

[19]  R. Reynolds,et al.  5,5-disubstituted hydantoins: syntheses and anti-HIV activity. , 1992, Journal of medicinal chemistry.

[20]  L. Frye,et al.  Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein--protein interaction. , 2001, Journal of the American Chemical Society.

[21]  C. Bertolotto,et al.  BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes. , 2001, Pigment cell research.

[22]  Jae-Kwan Hwang,et al.  Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. , 2004, Biological & pharmaceutical bulletin.

[23]  E. Monzani,et al.  Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid , 2000, JBIC Journal of Biological Inorganic Chemistry.

[24]  J. Nordlund The pigmentary system : physiology and pathophysiology , 1998 .

[25]  Wolfgang Löscher,et al.  Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor. , 2003, Journal of medicinal chemistry.

[26]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Kenji Matsumoto,et al.  Gnetol as a Potent Tyrosinase Inhibitor from Genus Gnetum , 2003, Bioscience, biotechnology, and biochemistry.

[28]  Jun Sik Lee,et al.  Antimelanogenic Activity of 3,4-Dihydroxyacetophenone: Inhibition of Tyrosinase and MITF , 2006, Bioscience, biotechnology, and biochemistry.

[29]  C. A. Ramsden,et al.  Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.

[30]  P. Wong,et al.  Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study. , 2004, Journal of medicinal chemistry.

[31]  Tirso Pons,et al.  Homology modeling, model and software evaluation: three related resources , 1998, Bioinform..

[32]  S. Rhee,et al.  Inhibition of tyrosinase by green tea components. , 1999, Life sciences.

[33]  T. Igarashi,et al.  Synthesis and antiarrhythmic activity of 2,2-dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones. , 1992, Chemical & pharmaceutical bulletin.

[34]  M. Fukuda,et al.  Arbutin: mechanism of its depigmenting action in human melanocyte culture. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  H. Chung,et al.  4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor. , 2007, Biological & pharmaceutical bulletin.

[36]  F. García-Cánovas,et al.  Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. , 1993, The Biochemical journal.

[37]  M. Mor,et al.  5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. , 2006, Bioorganic & medicinal chemistry letters.

[38]  T. Pedley,et al.  Advances in the medical treatment of epilepsy. , 1998, Annual review of medicine.

[39]  J. Menéndez,et al.  Synthesis, anticonvulsant and antihypertensive activity of diastereomeric 9,10-dimethoxy-1,3,4,6,7,11b-hexahydrospiro-[benzo[a]quinolizin-2,4-imidazolidine]2',5'-diones , 1992 .

[40]  M. Koyama,et al.  An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.

[41]  Irwin D. Kuntz,et al.  Development and validation of a modular, extensible docking program: DOCK 5 , 2006, J. Comput. Aided Mol. Des..

[42]  J. Chung,et al.  Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. , 2002, Cellular signalling.

[43]  A. Nias,et al.  Effect of azelaic acid on melanoma cells in culture , 1995, Experimental dermatology.

[44]  J. Knabe,et al.  Razemate und Enantiomere basisch substituierter 5-Phenylhydantoine, Synthese und antiarrhythmische Wirkung , 1997 .

[45]  Tetsuro Ito,et al.  Inhibitory Effects of Resveratrol Derivatives from Dipterocarpaceae Plants on Tyrosinase Activity , 2003, Bioscience, biotechnology, and biochemistry.

[46]  A. Markovac,et al.  Hydantoins as antitumor agents. , 1977, Journal of medicinal chemistry.

[47]  Francisco Solano,et al.  Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.